# POMALIDOMIDE
> **ANDA210232** · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARMACEUTICAL INDUSTRIES LIMITED · Approved 2026-03-24
## Drug
- **FDA Application Number:** ANDA210232
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** POMALIDOMIDE
- **Generic name:** Pomalidomide
- **Active ingredients:** POMALIDOMIDE
- **Dosage form:** CAPSULE
- **Route:** —
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** SUN PHARMACEUTICAL INDUSTRIES LIMITED
- **First approval:** 2026-03-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210232)
---
*MORVS · CC0 1.0*